CN105652957A - Insulin regulating blood sugar control caliper - Google Patents

Insulin regulating blood sugar control caliper Download PDF

Info

Publication number
CN105652957A
CN105652957A CN201610179533.XA CN201610179533A CN105652957A CN 105652957 A CN105652957 A CN 105652957A CN 201610179533 A CN201610179533 A CN 201610179533A CN 105652957 A CN105652957 A CN 105652957A
Authority
CN
China
Prior art keywords
blood sugar
scale
chute
numerical value
along
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201610179533.XA
Other languages
Chinese (zh)
Other versions
CN105652957B (en
Inventor
郁慧杰
朱湘筠
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
First Hospital of Jiaxing
Original Assignee
First Hospital of Jiaxing
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by First Hospital of Jiaxing filed Critical First Hospital of Jiaxing
Priority to CN201610179533.XA priority Critical patent/CN105652957B/en
Publication of CN105652957A publication Critical patent/CN105652957A/en
Application granted granted Critical
Publication of CN105652957B publication Critical patent/CN105652957B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06CDIGITAL COMPUTERS IN WHICH ALL THE COMPUTATION IS EFFECTED MECHANICALLY
    • G06C3/00Arrangements for table look-up, e.g. menstruation table

Abstract

The invention relates to an insulin regulating blood sugar control caliper, which comprises a long-strip-shaped base ruler (1) and a long-strip-shaped slide ruler (2), wherein the sliding ruler is embedded in a chute (6) formed in the base ruler; scales (3) for indicating the blood sugar values of the former times are marked on the upper edge (7) of the chute (6) of the base ruler along the length direction; the values of the scales are gradually increased from the left side to the right side; scales (4) used for indicating the insulin regulating quantity are marked on the lower edge (8) of the chute (6) of the base ruler along the length direction; scales (5) for indicating the blood sugar value of the current time are marked on the upper edge of the slide ruler along the length direction; the values, the gradually changing direction and the interval sizes of the scales (5) are identical to those of the scales for indicating the blood sugar values of the former times marked on the upper edge of the chute of the base ruler; scales (9) for indicating the blood sugar value of the current time are also marked on the lower edge of the slide rule along the length direction. The insulin regulating blood sugar control caliper has the advantages that the slide ruler can move according to the blood sugar change condition of a patient; the correct regulating quantity of the insulin injection can be found out; the clinic use is convenient; the complicated calculation is avoided.

Description

Regular Insulin regulates glycemic control slide calliper rule
Technical field
The present invention relates to a kind of therapeutic medical instrument, a kind of Regular Insulin regulates glycemic control slide calliper rule.
Background technology
It is the common pathological phenomenon of critically ill patients that the exception of blood sugar raises with reducing, and is one of the independent hazard factor of Severe acute disease death, and rational blood sugar monitoring and control method are the important steps in Severe acute disease patient's wholistic therapy. U.S.'s severe medical science meeting (SCCM) has issued in 2012 " infusion of insulin treatment severe patient's hyperglycemia guide ", and advise definitely controlling at below 180mg/dl glucose level, and avoid lower than 70mg/dl (18mg/dl=1mmol/L), and provide preliminary glycemic control methods. Though domestic existing without associated guideline, but the glycemic control problem of Severe acute disease patient is just more and more taken seriously. The control mode of Severe acute disease patient's blood sugar mainly adopts the method that syringe pump intravenous insulin injects, the experience regulating main foundation medical personnel at present of blood sugar monitoring and insulin dosage, but the gap due to working experience, to insulin dosage without unified adjustment criteria, this just causes the higher degree of variation of Cavity in Critical Patients blood sugar, therefore on existing glycemic control methods basis, improve a kind of sequencing glycemic control mode unifying specification, avoid the uncertainty of experience factor, just seem very necessary.
Summary of the invention
The present invention is intended to propose a kind of Regular Insulin and regulates glycemic control slide calliper rule, according to patient's stress situation severity, blood sugar degree of variation and Regular Insulin consumption, can find suitable insulin dosage fast, it is achieved the sequencing glycemic control of unified specification.
This kind of Regular Insulin regulates glycemic control slide calliper rule to comprise the base chi of long strip shape and the slide rule of long strip shape, there is a chute through along its length at the middle part of base chi, slide rule is entrenched in the above-mentioned chute of base chi, along the upper scale indicating previous blood sugar numerical value along its length on the chute of base chi, the numerical value of this scale increases gradually from from left to right; The chute of base chi lower to the upper scale indicating Regular Insulin regulated quantity along its length, in this scale, left section for being just worth and reducing gradually from from left to right, stage casing is constant, and right section for negative value and reduces gradually from from left to right, and the rightest section for suspending; The upper edge of slide rule indicates the scale of this blood sugar numerical value along its length, on the chute of the numerical value of this scale, alternation direction and gap size and base chi, scale along upper previous blood sugar numerical value is identical, the lower edge of slide rule also indicates the scale of this blood sugar numerical value along its length, and the numerical value right-to-left of this scale increases gradually.
This kind of Regular Insulin regulates glycemic control slide calliper rule can move slide rule according to the change conditions of the blood glucose value of patient, finds the correct regulated quantity of infusion of insulin, can facilitate Clinical practice, avoids loaded down with trivial details calculating.
Accompanying drawing explanation
Fig. 1 is the front view that Regular Insulin regulates glycemic control slide calliper rule;
Fig. 2 is the stereographic map of base chi,
Fig. 3 is the stereographic map of slide rule;
Fig. 4 is the first application drawing that Regular Insulin regulates glycemic control slide calliper rule;
Fig. 5 is the 2nd kind of application drawing that Regular Insulin regulates glycemic control slide calliper rule.
Embodiment
As shown in Figure 1, this kind of Regular Insulin regulates glycemic control slide calliper rule to comprise the base chi 1 of long strip shape and the slide rule 2 of long strip shape. As shown in Figure 2, there is a chute 6 through along its length at the middle part of base chi 1, and slide rule 2 is entrenched in the above-mentioned chute of base chi. Indicating the scale 3 of previous blood sugar numerical value on the chute 6 of base chi along 7 along its length, the numerical value of this scale increases gradually from from left to right; The lower scale 4 indicating Regular Insulin regulated quantity along 8 along its length of the chute 6 of base chi, in this scale, left section is just be worth and reducing gradually from from left to right, and stage casing is constant, and right section for negative value and reduces gradually from from left to right, and the rightest section for suspending. As shown in Figure 3, the upper edge of slide rule 2 indicates the scale 5 of this blood sugar numerical value along its length, on the chute 6 of the numerical value of this scale, alternation direction and gap size and base chi 1, the scale 3 of the previous blood sugar numerical value along 7 is identical, the lower edge of slide rule also indicates the scale 9 of this blood sugar numerical value along its length, and the numerical value right-to-left of this scale 9 increases gradually.
This kind of Regular Insulin regulate the slide rule 2 of glycemic control slide calliper rule on scale 5 along this upper blood sugar numerical value contrary with the lower alternation direction along the scale 9 of this blood sugar numerical value upper, and the Changing Pattern of the scale 4 of the lower Regular Insulin regulated quantity along 8 of the chute 6 of base chi just meets the requirement of infusion of insulin amount adjustment: infusion of insulin amount need to be increased during high blood glucose, high blood glucose must the increasing amount of more severe insulin infusion amount more big, infusion of insulin amount need to be reduced when blood sugar is on the low side, blood sugar is on the low side must the reduction of more severe insulin infusion amount more big, until suspending, when blood sugar is in normal range, infusion of insulin amount need not change.
This kind of Regular Insulin regulates the reference of glycemic control slide calliper rule to be of a size of:
1, the chute 6 of base chi on the scale 3 of previous blood sugar numerical value along 7 for be followed successively by 2,3,4,5,6,7,8,9,10,11,12,14,16,18,20,22,25,28 (mmol/L) from left to right, spacing is followed successively by 4mm, 5mm, 6mm, 7mm, 8mm, 9mm, 10mm, 10mm, 10mm, 10mm, 9mm, 8mm, 7mm, 6mm, 5mm, 4mm, 4mm from left to right.
2, the scale 5 of this blood sugar numerical value on the upper edge of slide rule 2 is for be followed successively by 2,3,4,5,6,7,8,9,10,11,12,14,16,18,20,22,25,28 (mmol/L) from left to right, and spacing is followed successively by 4mm, 5mm, 6mm, 7mm, 8mm, 9mm, 10mm, 10mm, 10mm, 10mm, 9mm, 8mm, 7mm, 6mm, 5mm, 4mm, 4mm from left to right.
3, the scale 9 of this blood sugar numerical value on the lower edge of slide rule 2 is for be followed successively by 28,25,22,20,18,16,14,12,11,10,9,8,7,6,5,4,3,2 (mmol/L) from left to right, and spacing is followed successively by 10mm, 10mm, 10mm, 10mm, 10mm, 10mm, 10mm, 10mm, 15mm, 10mm, 15mm, 10mm, 10mm, 10mm, 15mm, 10mm, 10mm from left to right.
4, the scale 4 of the lower Regular Insulin regulated quantity along 8 of the chute 6 of base chi for being followed successively by+100% from left to right ,+70% ,+50% ,+30% ,+20% ,+10%, constant ,-30% ,-50% ,-70%, suspend; Spacing is followed successively by 12mm, 18mm, 22mm, 11mm, 10mm, 7mm, 40mm, 17mm, 14mm, 8mm, 6mm, 20mm from left to right.
When the scale 3 of the previous blood sugar numerical value on base chi aligns with the scale 5 of this blood sugar numerical value on the upper edge of slide rule 2, in the lower Regular Insulin regulated quantity along 8 of the chute 6 of base chi, left one side of something is that this blood glucose value is when 11 28mmol/L, Regular Insulin needs the per-cent of the amount of adding, middle portion is that blood glucose value is when 8 11mmol/L, Regular Insulin can not regulate, right one side of something is that this blood sugar numerical value is when 2 8mmol/L, Regular Insulin needs the per-cent of appropriate decrement, even need to stop using and use high sugar to correct hypoglycemia, above design data meets the principle of " infusion of insulin treatment severe patient's hyperglycemia guide ". the oblique line 10 connecting the scale 5,9 on upper and lower edge on slide rule 2 is used to help in use reading.
This kind of Regular Insulin regulates glycemic control slide calliper rule use procedure to be exemplified below, as shown in Figure 4, if the previous blood sugar numerical value of patient is 10mmol/L, recording this blood sugar numerical value is 8mmol/L, mobile slide rule make the chute 6 along upper this blood sugar numerical value 8mmol/L and base chi on previous blood sugar numerical value 10mmol/L along 7 align, now it is correct regulated quantity along the lower Regular Insulin regulated quantity-45% along 8 of the chute 6 of the relative base chi of upper this blood sugar numerical value 8mmol/L under slide rule, also it is exactly infusion of insulin amount should be reduced 45%.
As shown in Figure 5, if the previous blood sugar numerical value of patient is 10mmol/L, recording this blood sugar numerical value is 9mmol/L, mobile slide rule make the chute 6 along upper this blood sugar numerical value 9mmol/L and base chi on previous blood sugar numerical value 10mmol/L along 7 align, it is now constant along the lower Regular Insulin regulated quantity along 8 of the chute 6 of the relative base chi of upper this blood sugar numerical value 9mmol/L under slide rule, also it is exactly that infusion of insulin amount need not change.

Claims (1)

1. a Regular Insulin regulates glycemic control slide calliper rule, comprise the base chi (1) of long strip shape and the slide rule (2) of long strip shape, there is a chute (6) through along its length at the middle part of base chi (1), slide rule (2) is entrenched in the above-mentioned chute of base chi, it is characterized in that indicating along its length on the upper edge (7) of the chute of base chi (6) scale (3) of previous blood sugar numerical value, the numerical value of this scale increases gradually from from left to right; The lower edge (8) of the chute (6) of base chi indicates the scale (4) of Regular Insulin regulated quantity along its length, in this scale, left section is just be worth and reducing gradually from from left to right, and stage casing is constant, right section for negative value and reduces gradually from from left to right, and the rightest section for suspending; The upper edge of slide rule indicates the scale (5) of this blood sugar numerical value along its length, the scale (3) of the previous blood sugar numerical value on the upper edge (7) of the numerical value of this scale, alternation direction and gap size and the chute (6) of base chi is identical, the lower edge of slide rule also indicates the scale (9) of this blood sugar numerical value along its length, and the numerical value right-to-left of this scale (9) increases gradually.
CN201610179533.XA 2016-03-25 2016-03-25 Insulin adjusts glycemic control slide calliper rule Active CN105652957B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610179533.XA CN105652957B (en) 2016-03-25 2016-03-25 Insulin adjusts glycemic control slide calliper rule

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610179533.XA CN105652957B (en) 2016-03-25 2016-03-25 Insulin adjusts glycemic control slide calliper rule

Publications (2)

Publication Number Publication Date
CN105652957A true CN105652957A (en) 2016-06-08
CN105652957B CN105652957B (en) 2018-03-20

Family

ID=56495624

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610179533.XA Active CN105652957B (en) 2016-03-25 2016-03-25 Insulin adjusts glycemic control slide calliper rule

Country Status (1)

Country Link
CN (1) CN105652957B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112515628A (en) * 2019-09-17 2021-03-19 小甑科技有限公司 Blood glucose management and control system

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3999041A (en) * 1976-01-08 1976-12-21 Joseph Scofield Summing calculator to assist analysis of past performance
CN2072702U (en) * 1990-01-13 1991-03-06 李正洪 Multi-functional clinical slide rule
JP3148657U (en) * 2008-11-17 2009-02-26 株式会社カーム HOMA-R calculation quick reference scale
CN104048739A (en) * 2013-03-14 2014-09-17 飞旸生医有限公司 Medicament dosage monitoring method and medicament dosage monitoring device
CN205563359U (en) * 2016-03-25 2016-09-07 嘉兴市第一医院 Blood sugar control slide caliper rule are adjusted to insulin

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3999041A (en) * 1976-01-08 1976-12-21 Joseph Scofield Summing calculator to assist analysis of past performance
CN2072702U (en) * 1990-01-13 1991-03-06 李正洪 Multi-functional clinical slide rule
JP3148657U (en) * 2008-11-17 2009-02-26 株式会社カーム HOMA-R calculation quick reference scale
CN104048739A (en) * 2013-03-14 2014-09-17 飞旸生医有限公司 Medicament dosage monitoring method and medicament dosage monitoring device
CN205563359U (en) * 2016-03-25 2016-09-07 嘉兴市第一医院 Blood sugar control slide caliper rule are adjusted to insulin

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112515628A (en) * 2019-09-17 2021-03-19 小甑科技有限公司 Blood glucose management and control system

Also Published As

Publication number Publication date
CN105652957B (en) 2018-03-20

Similar Documents

Publication Publication Date Title
US11040141B2 (en) Blood glucose control system with carbohydrate therapy indication
US11376362B2 (en) Systems for determining insulin on board and recommending insulin therapy and related methods
Ojo et al. Comparison of programmed intermittent epidural boluses with continuous epidural infusion for the maintenance of labor analgesia: a randomized, controlled, double-blind study
Rosenstock et al. Empagliflozin as add on to basal insulin for 78 weeks improves glycemic control with weight loss in insulin-treated type 2 diabetes (T2DM)
Tanaka et al. ED95 of phenylephrine to prevent spinal-induced hypotension and/or nausea at elective cesarean delivery
Wu et al. Risk factors and possible mechanisms of intravenous port catheter migration
Hakeam et al. Glargine insulin use versus continuous regular insulin in diabetic surgical noncritically ill patients receiving parenteral nutrition: randomized controlled study
Tan et al. Reducing breakthrough pain during labour epidural analgesia: an update
CN105652957A (en) Insulin regulating blood sugar control caliper
US20180085520A1 (en) Within-time infusion modes for infusion pumps
Moreno-Fernández et al. Commercialized hybrid closed-loop system (Minimed Medtronic 670G) results during pregnancy
CN205563359U (en) Blood sugar control slide caliper rule are adjusted to insulin
US11744938B2 (en) Titration for medical infusion devices and systems
Chan et al. Early blood pressure lowering does not reduce growth of intraventricular hemorrhage following acute intracerebral hemorrhage: results of the INTERACT studies
CN205563358U (en) Blood sugar fast check chi is adjusted to insulin
Morton et al. Intrathecal baclofen administration during pregnancy: a case series and focused clinical review
Salmaggi et al. Multicentre prospective collection of newly diagnosed glioblastoma patients: update on the Lombardia experience
Hayek Targeted Intrathecal Drug Delivery in Chronic Noncancer Pain: Best Practices
US20100137789A1 (en) Drug delivery presentation and arrangement for drug delivery presentation
JP2016187629A (en) Pre-operative use of metabolic activation therapy
CN111388796B (en) Timing device of injection pump and injection pump
US20140330245A1 (en) Delivery of a therapeutic agent via intermittent infusion
US20210213200A1 (en) Glucose control system with automated backup therapy protocol generation
Green et al. Cost-utility analysis alongside the PD SURG trial.
Guerrini et al. Hedgehog signalling pathway and Carbonic Anhydrases in Breast cancer cell physiology

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
EE01 Entry into force of recordation of patent licensing contract
EE01 Entry into force of recordation of patent licensing contract

Application publication date: 20160608

Assignee: Hangzhou Huaji Technology Co.,Ltd.

Assignor: The First Hospital of Jiaxing

Contract record no.: X2021980004389

Denomination of invention: Insulin regulating blood glucose control caliper

Granted publication date: 20180320

License type: Exclusive License

Record date: 20210604